精神分裂症共病代谢综合征的研究进展
Research Progress of Schizophrenia Comorbid Metabolic Syndrome
DOI: 10.12677/ACM.2020.1012481, PDF,    科研立项经费支持
作者: 宋京瑶, 李振阳, 庞 辉：重庆市长寿区第三人民医院精神科，重庆；王皋茂*：重庆医科大学附属大学城医院精神科，重庆
关键词: 精神分裂症；代谢综合征；影响因素；Schizophrenia； Mmetabolic Syndrome； Influence Factor
摘要: 精神分裂症共病代谢综合征(metabolic syndrome, MS)已成为精神医学领域的重要问题。精神分裂症共病MS的病理机制尚不明确，可能与遗传因素、炎性因子、下丘脑–垂体–肾上腺素轴等相关。目前，对于精神分裂症共病MS的治疗，首先，以纠正患者不良的生活方式。其次，选择合理的药物治疗及心理治疗也尤为重要。本文对精神分裂症共病MS的流行病学、影响因素以及治疗方案进行阐述，以期对精神科临床工作者提供参考依据。
Abstract: The schizophrenia comorbid metabolic syndrome has become an important issue in the field of psychiatry. At present, the pathological mechanism of schizophrenia comorbid (MS) is still not clear, probably related to genetic factors, inflammatory factors, and hypothalamic-pituitary-adrenergic axis, etc. It is believed that to treat MS, the first step is to correct the patient’s bad lifestyle. Besides, it is particularly important to choose reasonable medication and psychotherapy. This article describes the epidemiology, pathogenesis and treatment protocols of MS with the aim of providing reference for clinical practitioners.
文章引用：宋京瑶, 王皋茂, 李振阳, 庞辉. 精神分裂症共病代谢综合征的研究进展[J]. 临床医学进展, 2020, 10(12): 3214-3219. https://doi.org/10.12677/ACM.2020.1012481

参考文献

[1] Beltran-sanchez, H., Harhay, M.O., Harhaym, M., et al. (2013) Prevalence and Trends of Metabolic Syndrome in the Adult U.S. Population, 1999-2010. Journal of the American College of Cardiology, 62, 697-703. [Google Scholar] [CrossRef] [PubMed]
[2] Aguilar, M., Bhuket, T., Torres, S., et al. (2015) Prevalence of the Metabolic Syndrome in the United States, 2003-2012. JAMA: The Journal of the American Medical Association, 313, 1973-1974. [Google Scholar] [CrossRef] [PubMed]
[3] Ranasinghe, P., Mathangasinghe, Y., Jayawardena, R., et al. (2017) Prevalence and Trends of Metabolic Syndrome among Adults in the Asia-Pacific Region: A Systematic Review. BMC Public Health, 17, 101. [Google Scholar] [CrossRef] [PubMed]
[4] 闫慧敏, 张梅, 张笑, 等. 中国老年人代谢综合征流行特征及其影响因素研究[J]. 中华高血压杂志, 2019, 40(3): 284-289.
[5] Orellana, G., Rodriguez, M., Gonzalez, N., et al. (2017) The Association of Schizophrenia with Chronic Non Transmissible Diseases. Revista Médica de Chile, 145, 1047-1053. [Google Scholar] [CrossRef] [PubMed]
[6] Kassm, S.A., Hoertel, N., Naja, W., et al. (2019) Metabolic Syndrome among Older Adults with Schizophrenia Spectrum Disorder: Prevalence and Associated Factors in a Multicenter Study. Psychiatry Research, 275, 238-246. [Google Scholar] [CrossRef] [PubMed]
[7] Vancampfort, D., et al. (2015) Risk of Metabolic Syndrome and Its Components in People with Schizophrenia and Related Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review and Meta-Analysis. World Psychiatry, 14, 339-347. [Google Scholar] [CrossRef] [PubMed]
[8] 钟远惠, 谢穗峰, 喻俊, 等. 780例长期住院精神分裂症患者代谢综合征患病调查[J]. 现代临床医学, 2017, 43(4): 105-107.
[9] Mitchell, M.A.J., Vancampfort, D., Sweers, K., et al. (2013) Prevalence of Meta-Bolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders: A Systematic Review and Meta-Analysis. Schizophrenia Bulletin, 39, 306-318. [Google Scholar] [CrossRef] [PubMed]
[10] 崔力军, 潘鑫, 朱洁琳, 等. BDNF基因rs6265多态性与首发精神分裂症患者伴发糖代谢异常的相关性研究[J]. 医学研究杂志, 2017, 46(7): 87-90.
[11] 徐静文, 刘群, 管晓波, 等. 黑素皮质素受体-4基因rs489693位点多态性与慢性精神分裂症患者体质量指数及糖脂代谢水平的关系[J]. 临床精神医学杂志, 2018, 28(6): 382-386.
[12] 陈艳, 方新宇, 汪也微, 等. 中国汉族人泛醌NADH脱氢酶Fe-S蛋白1基因多态性与氯氮平所致代谢综合征的关联研究[J]. 临床精神医学杂志, 2020, 30(2): 77-81.
[13] Burghardt, K.J., Goodrich, J.M., Lines, B.N., et al. (2018) The Influence of Metabolic Syndrome and Sex on the DNA Methylome in Schizophrenia. International Journal of Genomics, 2018, Article ID: 8076397. [Google Scholar] [CrossRef] [PubMed]
[14] Enez, D.A., Yalcin, C.S., Dilbaz, N., et al. (2015) Metabolic Syndrome in Drug Naive and Drug-Free Patients with Schizophrenia and in Their Siblings. Schizophrenia Research, 166, 201-206. [Google Scholar] [CrossRef] [PubMed]
[15] 姚献虎, 夏磊, 李文正. 精神分裂症患者伴发代谢综合征与超敏C反应蛋白水平的相关研究[J]. 中国全科医学, 2020, 23(3): 294-298.
[16] 尚翠华. 急性期精神分裂症伴发代谢综合征与瘦素、脂联素等因子的关系[D]: [硕士学位论文]. 秦皇岛: 华北理工大学, 2018.
[17] Mori, N., McEvoy, J.P. and Miller, B.J. (2015) Total and Differential White Blood Cell Counts, Inflammatory Makers, Adipokines, and the Metabolic Syndrome in Phase 1 of the Clinical Antipsychotic Trials of Intervention Effectiveness Study. Schizophrenia Research, 169, 30-35. [Google Scholar] [CrossRef] [PubMed]
[18] Aly El-Gabry, D.M., Abdel, A.K., Okasha, T., et al. (2018) Antipsychotic Polypharmacy and Its Relation to Metabolic Syndrome in Patients with Schizophrenia: An Egyptian Study. Journal of Clinical Psychopharmacology, 38, 27-33. [Google Scholar] [CrossRef] 
[19] 李娜娜, 吴艳琴, 江沛, 等. 非典型抗精神病药物致脂代谢不良反应的基因多态性研究进展[J]. 中国临床药理学杂志, 2017(33): 1284-1287.
[20] Cortes, B., Becker, J., Mories Alvarez, M.T., et al. (2014) Contribution of Baseline Body Mass Index and Leptin Serum Level to the Prediction of Early Weight Gain with Atypical Antipsychotics in Schizophrenia. Psychiatry and Clinical Neurosciences, 68, 127-132. [Google Scholar] [CrossRef] [PubMed]
[21] 侯楠楠. 长期口服抗精神病药物患者的血液生化指标变化[J]. 检验医学与临床, 2019, 16(21): 3138-3140.
[22] Penninx, B.W. and Lange, S.M. (2018) Metabolic Syndrome in Psychiatric Patients: Overview, Mechianisms, and Implicatons. Dialogues in Clinical Neuroscience, 20, 63-72. [Google Scholar] [CrossRef] 
[23] 赵婧, 李存保, 康毅敏. 精神分裂症患者发生代谢综合征影响因素研究现状[J]. 疾病监测与控制, 2019, 13(1): 52-55.
[24] 谢继群, 余为陆, 欧阳少维, 钟远惠, 张志滨. 门诊精神分裂症患者代谢综合征发生率及相关危险因素的调查分析[J]. 中国当代医药, 2018, 25(24): 56-58.
[25] 王培培, 孙振晓. 抗精神病药物所致代谢综合征的治疗进展[J]. 山东医学高等专科学校学报, 2020, 42(1): 57-60.
[26] 张京涛, 刘西和, 王玲玲, 等. 阿立哌唑对女性精神分裂症患者服用奥氮平引起的代谢综合征的临床效果分析[J]. 中国社区医师, 2020, 36(9): 23-24.
[27] 陈美英, 陈尚坤, 袁也丰, 等. 替换阿立哌唑对儿童、青少年精神分裂症伴代谢综合征的影响[J]. 实用临床医学, 2017, 18(7): 59-62.
[28] 张清清. 二甲双胍对非典型抗精神病药物所致代谢综合症的影响[J]. 中国健康心理学杂志, 2017, 25(10): 1476-1478.
[29] 姜雨微, 姜文海, 马连华, 等. 瑞舒伐他汀在精神科中的应用[J]. 医学综述, 2016, 22(13): 2603-2606.
[30] Lu, M.L., Chen, T.T., Kuo, P.H., et al. (2018) Effects of Adjunctive Fluvoxamine on Metabolic Parameters and Psychopathology in Clozapine-Treated Patients with Schizophrenia: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study. Schizophrenia Research, 193, 126-133. [Google Scholar] [CrossRef] [PubMed]
[31] 周梦迪. 叶酸、维生素B_(12)早期干预对精神分裂症患者治疗过程中糖脂代谢变化的影响[D]: [硕士学位论文]. 保定: 河北大学, 2019.
[32] 陈莉, 魏晓云. 六郁汤辅助治疗精神分裂症伴发代谢综合征的临床研究[J]. 中医药导报, 2019, 25(16): 82-86.
[33] 周兆新, 刘亮, 毛静宇, 等. 高强度间歇训练对慢性精神分裂症患者代谢综合征的影响[J]. 中国健康心理学杂志, 2020, 28(11): 1604-1608.
[34] 周波, 高晓峰, 金庞, 等. 精神康复联合饮食控制对长期精神分裂症伴代谢综合征患者的疗效及社会功能影响分析[J]. 中国医刊, 2020, 55(1): 95-98.
[35] 吴晓优, 土文珍, 林小容, 等. 认知行为疗法对首发精神分裂症康复期患者糖脂代谢及临床疗效的影响[J]. 浙江医学, 2020, 42(10): 1073-1072.

为你推荐